Capsular Polysaccharide as a Potential Target in Hypervirulent and Drug-Resistant Klebsiella pneumoniae Treatment

被引：0
作者：
Ke, Yiying [1 ,2 ]
Zeng, Zhangrui [2 ,3 ,4 ]
Liu, Jinbo [2 ,3 ,4 ]
Ye, Caihong [2 ,3 ,4 ]
机构：
[1] Southwest Med Univ, Dept Clin Med, Luzhou, Peoples R China
[2] Southwest Med Univ, Dept Lab Med, Affiliated Hosp, Luzhou 646000, Peoples R China
[3] Sichuan Prov Engn Technol Res Ctr Mol Diag Clin Di, Luzhou 646000, Peoples R China
[4] Mol Diag Clin Dis Key Lab Luzhou, Luzhou 646000, Peoples R China
来源：
INFECTION AND DRUG RESISTANCE | 2025年 / 18卷
关键词：
capsular polysaccharide; hypervirulent; Klebsiella pneumoniae; drug-resistance; bacteriophages; CARBAPENEM-RESISTANCE; HYPERMUCOVISCOSITY;
D O I：
10.2147/IDR.S493635
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Klebsiella pneumoniae is a common cause of antimicrobial-resistant opportunistic infections in hospitalized patients. Hypervirulent Klebsiella pneumoniae (hvKP) acquiring exogenous resistance-encoding and hypervirulence-encoding genetic elements tend to develop both high virulence and resistance. The management of hvKP has also been made more difficult. Capsular polysaccharide (CPS) is the most important virulent factor of hvKP. The high degree of heterogeneity of the CPS and its hindering function adds difficulties in finding a general therapeutic approach. Thus, it is imperative to develop effective ways to target the CPS. The development of CPS-targeting phage treatment has spurred scientific interest. CPS relative vaccines show great potential as therapeutic alternatives to the currently ineffective antibiotics. To find out new ideas for clinical practice, we reviewed the molecular pathogenesis of K. pneumoniae, discussed the biological functions and regulatory factors of CPS. We studied the roles of CPS in virulence, drug resistance, and treatment of K. pneumoniae, and preliminarily investigated the viability of CPS as a target for prevention and therapy of K. pneumoniae infection.
引用
收藏
页码：1253 / 1262
页数：10
相关论文
共 85 条
  • [1] Shon AS, Bajwa RP, Russo TA., Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed, Virulence, 4, 2, pp. 107-118, (2013)
  • [2] Cheng YH, Huang TW, Juan CH, Et al., Tigecycline-non-susceptible hypervirulent Klebsiella pneumoniae strains in Taiwan, J Antimicrob Chemother, 75, 2, pp. 309-317, (2020)
  • [3] Duperthuy M., Antimicrobial peptides: virulence and resistance modulation in gram-negative bacteria, Microorganisms, 8, 2, (2020)
  • [4] Guerra MES, Destro G, Vieira B, Et al., Klebsiella pneumoniae Biofilms and Their Role in Disease Pathogenesis, Front Cell Infect Microbiol, 12, (2022)
  • [5] Haudiquet M, Buffet A, Rendueles O, Rocha EPC., Interplay between the cell envelope and mobile genetic elements shapes gene flow in populations of the nosocomial pathogen Klebsiella pneumoniae, PLoS Biol, 19, 7, (2021)
  • [6] Cheng HY, Chen YS, Wu CY, Chang HY, Lai YC, Peng HL., RmpA regulation of capsular polysaccharide biosynthesis in Klebsiella pneumoniae CG43, J Bacteriol, 192, 12, pp. 3144-3158, (2010)
  • [7] Walker KA, Miner TA, Palacios M, Et al., A Klebsiella pneumoniae regulatory mutant has reduced capsule expression but retains hypermucoviscosity, mBio, 10, 2, (2019)
  • [8] Ovchinnikova OG, Treat LP, Teelucksingh T, Et al., Hypermucoviscosity regulator RmpD interacts with Wzc and controls capsular polysaccharide chain length, mBio, 14, 3, (2023)
  • [9] Palacios M, Miner TA, Frederick DR, Et al., Identification of two regulators of virulence that are conserved in Klebsiella pneumoniae classical and hypervirulent strains, mBio, 9, 4, (2018)
  • [10] Lin CT, Huang TY, Liang WC, Peng HL., Homologous response regulators KvgA, KvhA and KvhR regulate the synthesis of capsular polysaccharide in Klebsiella pneumoniae CG43 in a coordinated manner, J Biochemistry, 140, 3, pp. 429-438, (2006)
123456789